Official Association • Est. 2025

Advancing evidence‑based medical marijuana for patient safety and clinician excellence.

AAMMJ sets national standards for clinical recommendations, patient verification, and continuing medical education. We collaborate with state boards, researchers, and clinicians to ensure safe, equitable access to therapeutic cannabis.

Our mission

Safety, science, standards.

AAMMJ develops consensus‑driven best practices that align with state and federal frameworks. We provide clinician toolkits, accreditation, and a verification system that payors and dispensaries can trust.

  • Peer‑reviewed clinical recommendations
  • Patient identity & recommendation verification
  • Doctor credentialing and CME programs
  • Policy advisories and compliance briefings
Clinical Guidance

Indications & Risk Management

Therapeutic cannabis may be considered for select conditions (e.g., chronic neuropathic pain, chemotherapy‑induced nausea) as part of a comprehensive care plan. Contraindications include unstable cardiovascular disease and pregnancy. Always evaluate for drug–drug interactions.

Read advisory principles
  • Use lowest effective THC dose; prefer balanced THC:CBD where appropriate.
  • Screen for psychosis risk and substance use disorder.
  • Document informed consent and response to therapy at each follow‑up.
  • Avoid inhalational routes for patients with chronic lung disease.
Authorized System

Patient Recommendation Verification

Enter the Recommendation ID and Date of Birth to verify status. Information returned is limited to what is necessary for verification purposes.

Patients

Have an invite code from your clinician? Submit it below to link your profile for a recommendation review.

Doctor Portal

Clinician Sign In

Protected by role‑based access, audit trails, and data minimization policies. Do not share credentials.